Eight common medicines for treating a variety of ailments now to get costlier, check details: Report

This comes after drug manufacturers issued applications to increase prices due to increased cost of ingredients, production, and exchange rates

Published on: Oct 16, 2024, 17:14:52 IST

By HT News Desk

Prefer HTon Google

Share via

Copy link

Eight common medicines for treating Asthma, Glaucoma, Thalassemia, Tuberculosis, and even mental health disorders like Bipolar Disorder, will get costlier because the National Pharmaceutical Pricing Authority (NPPA) has approved a price hike for 11 scheduled formulations of these medicines by 50% of their current ceiling price, according to a Financial Express report.

Also Read: First electric Royal Enfield to be unveiled on November 4, may be named ‘Flying Flea’

This comes after drug manufacturers issued applications to increase prices due to increased cost of ingredients, production, and exchange rates, according to the report.

The ceiling prices for which formulations have been increased?

The formulations for which the ceiling prices have been revised include the following:

Benzyl Penicillin 10 lakh IU injection
Atropine injection 06.mg/ml
Streptomycin powder for injection 750 mg and 1000 mg
Salbutamol tablet 2 mg and 4 mg and respirator solution 5 mg/ml
Pilocarpine 2% drops
Cefadroxil tablet 500 mg
Desferrioxamine 500 mg for injection
Lithium tablets 300 mg

Also Read: DA hiked by 3% for all central government employees ahead of Diwali

This comes after prices of 21 and 9 formulations were increased by 50% in 2019 and 2021 respectively.

The NPPA also fixed the retail price of 20 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013, according to the report.

The regulator also fixed the retail price of the cefuroxime axetil tablet from Dr Reddy’s Laboratories, L- Carnitinr mecobalamin and folic acid tablet from cadila Pharmaceuticals.

Also Read: New AI-based human capital management venture may come soon by IPO-bound OfBusiness co-founder Nitin Jain: Report

ABOUT THE AUTHOR
HT News Desk
Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.